Since 1986 Visx been guiding several procedures for the treatment of pathologies of the cornea and refractive eye diseases through FDA approval multistep process. The costs associated with providing information in FDA clinical trials were taking toll. Problems have risen sharply in September 1994, when the stock price Visx fell by 26% with the news that the FDA approval was delayed due to compliance violations found at some of the clinical trials. And in the same year, its revenue fell by 19%. Obtaining FDA approval is essential Visx, as it will have your foot in the door and be able to sell its excimer laser system in the United States. Persistent feelings of the management team was that although it was technologically more Visx laser system, which has consistently received top rankings from leading ophthalmologists world competition Visx was going to win the race to get FDA approval because of relentlessly aggressive and street smart. "Hide
by Gosia Glinskaya, Philippe Sommer Source: University of Virginia Darden School Foundation 14 pages. Publication Date: March 25, 2009. Prod. #: UV2713-PDF-ENG
Related Case Solutions & Analyses:
Erika James: The Life and Career of an Associate Professor
Trome: News for the Base of the Pyramid
Focused e-Tail Measurement and Resource Management
Nortel Networks Business Ventures Group: One Corporations Take on Entrepreneurship
Strategic Consensus: Marching to the Beat of a Different Drummer
Market Segmentation Strategies and Service Sector Productivity
PDQ Manufacturing Inc.
Tata Steel Zoological Park
Peking University People’s Hospital: An IT-Led Upgrading in the New Healthcare Reform
Education & Participation Award: ITAU-CENPEC-UNICEF Partnership, Portuguese Version
